Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Supported by numerous randomized controlled trials for knee osteoarthritis, tennis elbow, Achilles tendinopathy, and more
As GLP-1 therapies become a long-term cornerstone in diabetes care, monitoring patients on these treatments is gaining renewed attention
Wegovy is FDA-approved for long-term weight management in adults who are fat or overweight and who suffer from at least one weight-related illness, such as type 2 diabetes, high blood pressure, or high cholesterol
This helps many patients lose weight and control blood sugar
In a Phase 2 clinical trial published in the New England Journal of Medicine (Jastreboff et al., 2023), participants using retatrutide experienced up to 24% reduction in body weight over 48 weeks, significantly outperforming earlier GLP-1 agents
Metabolic Testing To ensure that our approach is as effective as possible, we utilize advanced tools for metabolic testing
